搜索临床试验以:Safety & tolerability
总计45516个结果
-
Duke Street Bio Ltd尚未招聘具有同源重组缺陷 (HRD) 的晚期恶性肿瘤(乳腺癌、卵巢癌、mCRPC、脑转移瘤)
-
Chengdu Origen Biotechnology Co., Ltd.尚未招聘
-
Zhejiang Sunshine Mandi Pharmaceutical Co.,Ltd.尚未招聘
-
Shanghai Jiaolian Drug Research and Development...Shanghai Pharmaceuticals Holding Co., Ltd尚未招聘
-
Fujian Shengdi Pharmaceutical Co., Ltd.尚未招聘
-
National Institute of Allergy and Infectious Diseases...KBio Inc尚未招聘
-
Angiex, Inc.招聘中
-
Spot Biosystems Ltd.Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University尚未招聘
-
Massachusetts General HospitalPatient-Centered Outcomes Research Institute尚未招聘
-
Ascendis Pharma Growth Disorders A/S尚未招聘
-
Ionis Pharmaceuticals, Inc.尚未招聘甲基 CpG 结合蛋白 2 (MECP2) 重复综合征
-
Regeneron Pharmaceuticals尚未招聘
-
University of FlorenceAzienda Ospedaliera Città della Salute e della Scienza di Torino; University of Roma La Sapienza 和其他合作者招聘中
-
Bill & Melinda Gates Medical Research Institute尚未招聘
-
TOLREMO therapeutics AG招聘中
-
Shanghai Yao Yuan Biotechnology Ltd. (also known...尚未招聘
-
Sunshine Guojian Pharmaceutical (Shanghai) Co.,...招聘中
-
Peking Union Medical College Hospital尚未招聘杜氏肌营养不良症 (DMD)
-
GRIN Therapeutics, Inc.招聘中结节性硬化症 | 局灶性皮质发育不良西班牙, 英国, 澳大利亚, 比利时, 加拿大, 意大利, 波兰